About This Page
This is a clinician-written, evidence-based guide aligned to the MCC Examination Objectives. It is structured by clinical presentation — the way the MCCQE tests and the way patients actually present. Management reflects current Canadian guidelines (CMA, CFPC, CPS). Always cross-reference with institutional protocols and clinical judgment.
The Bottom Line
- Pancytopenia means all three marrow-derived cell lines are low — identify febrile neutropenia or bleeding risk immediately, then separate marrow failure/infiltration from peripheral destruction or splenic sequestration.
- Start with acuity and stability before narrowing the differential.
- Use CBC with differential, smear, coagulation studies and targeted tests according to the presentation pattern.
- Escalate urgently for abnormal smear, systemic red flags, major bleeding, sepsis, thrombosis, neurologic symptoms or suspected malignancy.
- Management is cause-directed and should follow Canadian transfusion, thrombosis and cancer diagnostic pathway principles.
Approach to the Presentation
Pancytopenia is approached as a clinical presentation rather than as a single diagnosis. Begin by assessing stability, bleeding or thrombosis risk, infection/sepsis features, medication exposures, pregnancy status where relevant, and systemic red flags. Then use the pattern of the abnormality — CBC lineage, smear morphology, coagulation pathway, node distribution, spleen size, or VTE pre-test probability — to select focused investigations. For MCCQE1, the safest answer is usually the one that identifies must-not-miss disease while avoiding reflex treatment of an isolated laboratory value.
Differential Diagnosis
| diagnosis | likelihood | key features | distinguishing test |
|---|---|---|---|
| Acute leukemia | must-not-miss | Fever, infections, bruising, bleeding, bone pain, fatigue, lymphadenopathy, hepatosplenomegaly; blasts may be present. | CBC/smear, flow cytometry, bone marrow biopsy. |
| Aplastic anaemia | must-not-miss | Pancytopenia with hypocellular marrow, infections/bleeding/fatigue, usually no splenomegaly; drug, viral, autoimmune or idiopathic. | Bone marrow biopsy showing hypocellularity; exclude PNH, MDS and inherited marrow failure. |
| Myelodysplastic syndrome | must-not-miss | Older adult, macrocytosis, dysplastic neutrophils/platelets, recurrent infections or bruising, chronic cytopenias. | Bone marrow biopsy with cytogenetics. |
| Febrile neutropenia with pancytopenia | must-not-miss | Fever with low neutrophils, chemotherapy or marrow disease, mucositis, sepsis risk; may look deceptively well. | CBC with ANC; cultures but immediate empiric antipseudomonal antibiotics. |
| Vitamin B12 or folate deficiency | common | Macrocytosis, glossitis, neuropathy, cognitive changes, malnutrition, metformin/PPI use, vegan diet. | B12/folate, methylmalonic acid/homocysteine, smear with hypersegmented neutrophils. |
| Hypersplenism from portal hypertension or splenic disease | common | Splenomegaly, liver disease signs, thrombocytopenia often prominent, mild-moderate leukopenia/anaemia. | Abdominal ultrasound, liver tests, INR/albumin, portal hypertension assessment. |
| Medication/toxin-induced marrow suppression | common | Chemotherapy, methotrexate, azathioprine, TMP-SMX, anticonvulsants, antithyroid drugs, linezolid, alcohol. | Medication/toxin timeline; recovery after cessation if reversible; marrow if severe/persistent. |
| HIV, hepatitis, EBV/CMV, parvovirus, TB | less common | Fever, lymphadenopathy, exposure risks, hepatitis signs, immunosuppression or travel. | Targeted infectious testing and cultures/imaging based on presentation. |
| Autoimmune disease (SLE) | less common | Cytopenias with rash, arthritis, serositis, renal disease, photosensitivity or oral ulcers. | ANA, dsDNA, complements, urinalysis and clinical criteria. |
| Bone marrow infiltration by metastatic cancer, lymphoma or myelofibrosis | less common | Weight loss, night sweats, bone pain, teardrop cells, leukoerythroblastosis, splenomegaly. | Smear, imaging and bone marrow biopsy. |
Red Flags & Key History
Symptoms
Fever or rigors with neutropenia — febrile neutropenia/sepsis emergency
Mucosal bleeding, melena, hematuria or severe bruising — thrombocytopenic bleeding risk
Dyspnea at rest, chest pain or syncope — severe symptomatic anaemia
Bone pain, night sweats, weight loss or recurrent infections — leukemia/lymphoma/marrow infiltration
New medications, chemotherapy, radiation, alcohol, toxins or occupational exposure
Neuropathy, glossitis, dietary restriction, metformin/PPI — B12 clues
Signs
Fever, hypotension, mucositis or catheter infection signs
Petechiae, purpura or oral blood blisters
Lymphadenopathy, hepatosplenomegaly or sternal tenderness
Neurologic signs of B12 deficiency
Stigmata of chronic liver disease and splenomegaly
Approach to Investigation
First-line
Repeat CBC with differential, ANC and reticulocyte countConfirm pancytopenia, quantify neutropenia and determine marrow response.
Peripheral smearBlasts, dysplasia, hypersegmented neutrophils, teardrops, leukoerythroblastosis, schistocytes, atypical lymphocytes.
B12, folate, iron studies, creatinine, liver tests, LDH, bilirubin, haptoglobinScreen nutritional deficiency, haemolysis, renal/liver disease and high cell turnover.
Infectious testing based on riskHIV, hepatitis B/C, EBV/CMV, parvovirus B19, TB testing; blood cultures if febrile.
Second-line
Abdominal ultrasoundAssess splenomegaly, liver disease, portal hypertension, lymphadenopathy or masses.
Autoimmune screenANA, complements and urinalysis if SLE/autoimmune disease suspected.
Flow cytometryIf blasts, abnormal lymphocytes, CLL/lymphoma/leukemia suspected.
Specialist
Bone marrow aspirate and trephine biopsyCore test for unexplained, severe, persistent pancytopenia or abnormal smear.
Cytogenetics/molecular testingUsed for leukemia, MDS, MPN, aplastic anaemia/PNH workup.
Management Principles
MCC white blood cell abnormalities/anaemia objectives + Canadian Blood Services transfusion principles1
Immediate safety management
- Febrile neutropenia: urgent broad-spectrum antipseudomonal antibiotics after cultures if this does not delay treatment.
- Major bleeding or very low platelets: urgent haematology/transfusion support.
- Severe symptomatic anaemia: red cell transfusion using restrictive one-unit reassessment principles when stable.
2
Remove reversible causes
- Stop suspected marrow-suppressive drugs where clinically safe.
- Replace B12/folate/iron deficiencies; treat infection; manage alcohol-related marrow suppression and liver disease.
- Give clear fever safety-net advice in severe neutropenia.
3
Definitive management
- Urgent haematology referral for suspected leukemia, aplastic anaemia, MDS, infiltration or severe unexplained pancytopenia.
- Disease-specific therapy may include chemotherapy, immunosuppression, growth factors, transfusion support or transplant evaluation.
Complications & Pitfalls
- Fever plus neutropenia is an emergency: do not wait for culture results before antibiotics.
- Macrocytosis is not always B12: consider MDS and alcohol/liver disease.
- Do not miss blasts: the smear must be reviewed urgently.
- Hypersplenism is peripheral sequestration.
- Aplastic anaemia often lacks splenomegaly.
MCCQE1 Exam Tips
- 1Fever + ANC <0.5 = febrile neutropenia: immediate empiric antibiotics.
- 2Pancytopenia + blasts = acute leukemia; hypocellular marrow = aplastic anaemia; hypersegmented neutrophils = B12/folate deficiency.
- 3Teardrop cells and leukoerythroblastosis suggest marrow infiltration or myelofibrosis.
- 4B12 deficiency can cause pancytopenia and neurologic findings.
- 5A large spleen with mild pancytopenia suggests hypersplenism.
- 6Early haematology and transfusion medicine involvement is appropriate when severe cytopenias are present.
practicetest your knowledge on pancytopeniaApply what you've learnt with MCCQE1-style questions from the iatroX Q-Bank — haematologic & oncologic and beyond.
open q-bank